Products and Services

HTN Logo

HERO PM (Practice Management)

HERO CMS (Clinical Management System)

HERO CMS for PCRG (Primary Care Renewal Groups)

Pocket PC HERO™ application



For information on availability, pricing, and options for HTN products, please contact:

Call: 1-(888) I'M-A-HERO 1-(888) 462-4376


HERO™ for Windows

HTN Logo


AlphaHTN 1262 Don Mills Road,Toronto ON, M3B 2W7

(416) 975-0975


Technical support is available 9:00AM to 5:00PM EST, Monday through Friday.

Toronto/GTA:  (416) 975-4891
Outside Toronto/GTA: 1- (888) 437-6778  
Fax: (416) 975-0225
HTN Logo
HTN Inc. Shares Trade on the TSX Venture Exchange

Shares to Trade Under the New Symbol "HET"


Oakville, Ontario, Canada (July 19, 2001) - HTN Inc. (‘HTN’) (formerly Consolitech Invest Corp.) is pleased to announce that, in connection with the company’s successful completion of its acquisition of HTN (Ontario) Inc., a leading medical/healthcare information technology company and software support organization, and the acceptance of the acquisition as the company’s Qualifying Transaction (‘QT’) by the Canadian Venture Exchange (CDNX), common shares of HTN have been listed and posted for trading today on the CDNX as a Tier 2 issuer under the newly issued stock symbol "HET". HTN will be a reporting issuer in the provinces of Ontario, Alberta and British Columbia.

In preparation for this CDNX listing and prior to the acquisition of HTN (Ontario) Inc., the shareholders of Consolitech Invest Corp. (‘Consolitech’) passed a series of special resolutions on January 8, 2001, whereby Consolitech consolidated its common shares on a basis of 2 old shares for 1 new share. The name of Consolitech was changed from Consolitech Invest Corp. to HTN Inc. while, simultaneously, the shareholders of the acquired company, which was known at that time as HTN Inc. agreed to change its name to HTN (Ontario) Inc. Making these name changes enables the new public entity to maintain the existing goodwill and to be recognized by the existing customer base of the acquired company.

The reverse takeover acquisition of HTN (Ontario) Inc., involved Consolitech acquiring all of the issued and outstanding common shares of HTN (Ontario) Inc., by way of formal takeover bid, in exchange for 83,297,478 post-consolidation Consolitech shares at a deemed price of $0.10 per share for aggregate deemed consideration of $8,329,748. In addition, pursuant to a Private Placement by Consolitech of 4,930,000 post-consolidated special warrants on January 8, 2001, at a price of $0.10 per warrant, 4,930,000 common shares will be issued by the company at a conversion rate of one common share per warrant.

Since its inception in 1994, HTN (Ontario) Inc. has achieved rapid sales growth through a combination of organic growth and strategic acquisitions and now has over 1,700 medical providers using its products, with over 1,200 of these providers already connected to the company’s Health Transaction Network. In addition, HTN has a contractual agreement with a supplier of DOS-based software, to approximately 4,000 physicians, to have these users converted to HTN’s Windows™-based product HERO™. HTN is expected to also accelerate its sales growth by stepping-up its rate of strategic acquisitions.

According to HTN’s President, Gary Babcock, "In order to accelerate our acquisition strategy outlined in our business plan, HTN intends to pursue additional investment capital through private placement and/or public offerings and becoming a CDNX public company will help us accomplish this goal. As well, the company’s shares can now be considered as a form of currency and can be used to facilitate customized acquisition proposals. With recent announcements of massive funding by the Government of Canada, in conjunction with their Provincial counterparts, for the development of a pan-Canadian healthcare information network, HTN is now ideally positioned to become an important player in this process."

About HTN Inc.

HTN Inc. (an acronym for Health Transaction Network) is a medical/healthcare information technology company and software support organization, which pioneered the use of on-line healthcare transaction networks in the province of Ontario, Canada, where the company’s head office has been located since its inception in 1994. With its Windows™-based flagship product HERO TM; (Healthcare Electronic Resources On-line), HTN Inc. specializes in providing the latest in cost effective, computerized automation to medical offices, clinics, hospitals and other medical facilities providing them with improved workflow, faster information retrieval and overall operating efficiencies while seamlessly enabling them to electronically exchange/share clinical and transactional information with other healthcare facilities, providers, payers, insurers, patients, and suppliers.

Contact: Gary Babcock
Phone:	(416 )975-0975
Fax:	(416) 975-0225

This press release may contain forward-looking statements relating to the future performance of HTN Inc. Inc. Forward-looking statements, specifically those concerning future performance and the achievement of operating profitability, are subject to certain risks and uncertainties, and actual results may differ materially. These risks and uncertainties include the ability of the Corporation to identify, develop, manufacture and market new products or to enhance its existing products; the limited operating history of the Corporation; the fluctuation in operating results; the Corporation's ability to successfully integrate acquired businesses; intense competition in the healthcare information system software market; the early stage of development of some of the Corporation's products; rapidly changing technology; limits on the Corporation's ability to protect its proprietary rights and technology; the possibility of defects in the Corporation's software; the ability of the Corporation to manage its growth; dependence on key personnel; dependence on a few clients; dependence on distribution channels; risks associated with international sales; the potential for litigation of patent infringement claims; the uncertainty of obtaining financing for future capital needs; currency exchange risks and other risks and uncertainties described in the Corporation's prospectus and filings with the Ontario Securities Commission.